Multiple antiviral activities of the antimalarial and anti-hepatitis C drug candidates N-89 and N-251
Youki Ueda1, Weilin Gu1, Hiromichi Dansako1, Hye-Sook Kim2, Sayaka Yoshizaki3, Nobuaki Okumura1, Tomohiro Ishikawa4, Hironori Nishitsuji5, Fumihiro Kato6, Takayuki Hishiki7, Shinya Satoh1, Koji Ishii3, Michiaki Masuda4, Kunitada Shimotohno5, Masanori Ikeda8, Nobuyuki Kato1
1Department of Tumor Virology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Okayama 700-8558, Japan
2Division of International Infectious Diseases Control, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 1-1-1 Tsushimanaka, Okayama 700-8530, Japan
3Department of Virology II, National Institute of Infectious Diseases, 4-7-1 Gakuen, Musashi-murayama, Tokyo 208-0011, Japan
4Department of Microbiology, Dokkyo Medical University School of Medicine, 880 Kitakobayashi, Mibu-machi, Shimotsuga-gun, Tochigi 321-0293, Japan
5Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, 1-7-1 Kohnodai, Ichikawa, Chiba, 272-8575, Japan
6Department of Virology I, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku, Tokyo 162-8640, Japan
7Department of Microbiology and Cell Biology, Tokyo Metropolitan Institute of Medical Science, 2-1-6 Kamikitazawa, Setagaya-ku, Tokyo 150-8506, Japan
8Department of Persistent and Oncogenic Viruses, Center for Chronic Viral Disease, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima 890-8544, Japan
Tài liệu tham khảo
Thông tin
Thông tin xuất bản
Biochemistry and Biophysics Reports
Tập 15
1-6
Thông tin tác giả